M&A Deal Summary

ProStrakan Group Acquires Archimedes Pharma

On August 6, 2014, ProStrakan Group acquired life science company Archimedes Pharma from Warburg Pincus for 230M GBP

Acquisition Highlights
  • This is ProStrakan Group’s 1st transaction in the Life Science sector.
  • This is ProStrakan Group’s largest (disclosed) transaction.
  • This is ProStrakan Group’s 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2014-08-06
Target Archimedes Pharma
Sector Life Science
Buyer(s) ProStrakan Group
Sellers(s) Warburg Pincus
Deal Type Add-on Acquisition
Deal Value 230M GBP

Target

Archimedes Pharma

Reading, United Kingdom
Archimedes is a pharmaceutical company with an established commercial organisation in the UK, France, Germany, Ireland and Spain.

Search 198,242 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ProStrakan Group

Galashiels, United Kingdom

Category Company
Founded 2004
Sector Life Science
DESCRIPTION

ProStrakan Group plc was created in 2004 by the merger of Strakan Group plc and ProSkelia. The combined company, based in Galashiels, Scotland, is a rapidly growing international specialty pharmaceutical company engaged in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (United Kingdom) 1 of 1
Year (2014) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-12-22 ProSkelia SASU

Paris, France

ProSkelia SASU is a phamaceutical company the company R&D operations and a product portfolio of products focused on musculoskeletal diseases (osteoporosis, cachexia and bone metastasis).

Sell -

Seller(S) 1

SELLER

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.


DEAL STATS #
Overall 106 of 250
Sector (Life Science) 14 of 20
Type (Add-on Acquisition) 41 of 90
Country (United Kingdom) 10 of 17
Year (2014) 7 of 9
Size (of disclosed) 45 of 63
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-04 Aicent

San Jose, California, United States

Aicent, Inc. is a provider of data network, messaging and roaming solutions to telecom network operators internationally. The company provides a platform for cross-border and cross-network data delivery solutions to mobile network operators serving more than three billion mobile users worldwide.

Sell $292M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-08-19 Baosteel Metals

Shanghai, China

Baosteel Gases is one of the wholly-owned subsidiaries of Baosteel Metal, which has 15 subsidiaries across China. With core businesses covering from industrial gases to new energy products, the company has the capacity of comprehensive technology and development, marketing and logistics, M&A and full construction of air separation units and operation ability, with the biggest air separation units in South China.

Buy -